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&Activity-Based Probes
Photo Cross-Linking Probes Containing e-N-Thioacyllysine and
e-N-Acyl-(d-aza)lysine Residues**
Michael Bæk, Pablo Mart&n-Gago, Jonas S. Laursen, Julie L. H. Madsen, Saswati Chakladar,
and Christian A. Olsen*[a]
Abstract: Posttranslational modifications (PTMs) are impor-
tant in the regulation of protein function, trafficking, locali-
zation, and marking for degradation. This work describes the
development of peptide activity/affinity-based probes for
the discovery of proteins that recognize novel acyl-based
PTMs on lysine residues in the proteome. The probes con-
tain surrogates of e-N-acyllysine by introduction of either hy-
drazide or thioamide functionalities to circumvent hydrolysis
of the modification during the experiments. In addition to
the modified PTMs, the developed chemotypes were ana-
lyzed with respect to the effect of peptide sequence. The
photo cross-linking conditions and subsequent functionaliza-
tion of the covalent adducts were systematically optimized
by applying fluorophore labeling and gel electrophoresis (in-
gel fluorescence measurements). Finally, selected probes,
containing the e-N-glutaryllysine and e-N-myristoyllysine ana-
logues, were successfully applied for the enrichment of
native, endogenous proteins from cell lysate, recapitulating
the expected interactions of SIRT5 and SIRT2, respectively.
Interestingly, the latter mentioned was able to pull down
two different splice variants of SIRT2, which has not been
achieved with a covalent probe before. Based on this elabo-
rate proof-of-concept study, we expect that the technology
will have broad future applications for pairing of novel PTMs
with the proteins that target them in the cell.
Introduction
Posttranslational modifications (PTMs) are important in the reg-
ulation of protein function, trafficking, localization, and mark-
ing for degradation.[1] The effects and mechanisms of several
types of chemical modification to protein side chains have
been studied extensively, with particular attention dedicated
to phosphorylation,[2] ubiquitinylation,[3] and acetylation[4] thus
far. However, it has recently become evident that lysine side
chains may be decorated with a variety of different acyl
groups in addition to e-N-acetyllysine (Kac).[5] Examples of
these novel acyl PTMs include e-N-malonyllysine (Kmal),[6] e-N-
succinyllysine (Ksuc),[6, 7] e-N-glutaryllysine (Kglut),[8] e-N-croto-
nyllysine (Kcr),[9] e-N-phosphoglyceryllysine (Kpg),[10] e-N-myris-
toyllysine (Kmyr),[11] e-N-methylglutaconyllysine (Kmgc),[12] and
e-N-(3-hydroxy-3-methylglutaryl)-lysine (Khmg).[12] Except for
Kpg, the above-mentioned PTMs have all been shown to be
regulated by members of the histone deacylase (HDAC)
enzyme family. The human genome encodes 18 HDACs, the
Zn2+-dependent histone deacetylases (HDAC1-11)[13] and the
NAD+-dependent sirtuins (SIRT1-7).[14] Though originally classi-
fied as deacetylases, recent studies have revealed that SIRT5
targets Kmal, Ksuc, and Kglut,[6, 7c–e,8a] SIRT2 and SIRT6 regulate
the levels of Kmyr,[11b] SIRT4 regulates Kmgc and Khmg,[12,15]
Zn2+-dependent HDAC1-3 appear to be the major regulators
of Kcr,[16] and HDAC11 preferentially cleaves Kmyr.[17]
To complement the rapid rate of discovery of PTMs enabled
by advanced mass spectrometry-based proteomic investiga-
tions, we decided to develop a catalogue of chemical tools for
matching novel PTMs with their respective targeting proteins.
We envisioned that this could be achieved by applying the
concept of photo cross-linkable activity/affinity-based probes
(ABPs),[18] containing different e-N-acyllysine residues for recog-
nition of the PTM of interest. Examples of such ABPs have
been reported[19] but the inherent susceptibility of these sub-
strate-based probes, to PTM removal by HDAC/SIRT activity,
calls for alternative probe designs. Here, we describe an updat-
ed version of the previously reported probe concept by intro-
ducing amide bond analogues to avoid premature hydrolysis
of the interrogated PTMs (Figure 1).
The chosen amide bond analogues were either the thio-
amide functional group (X=CH2, Y=S), which has been em-
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ployed in mechanism-based SIRT inhibitors[20] or the d-azaly-
sine-based hydrazides described by Cole and co-workers (X=
NH, Y=O).[21] Both were selected due to their ability to form
so-called stalled intermediates with the NAD+ co-substrate in
the sirtuin active site, resulting in decreased rates of hydroly-
sis.[20g] Encouragingly, Cen and co-workers recently reported on
an ABP, containing a e-N-thioacetyllysine that could successful-
ly label overexpressed SIRT2 in HEK293 cells, providing further
impetus for this concept.[22]
Results and Discussion
Design and synthesis of photo cross-linking probe collection
For a proof-of-concept probe collection, decameric peptides
were chosen to allow several amino acids to flank the modified
lysine residue. To assess the effect of the peptide sequence to-
gether with the PTM of interest, the four selected sequences
were based around lysine residues that are known to be deco-
rated with the different PTMs investigated in this study. Thus,
in order to investigate Kac and Kcr the histone sequences
around histone 4-Lys12 (H4K12) and histone 3-Lys9 (H3K9)
were chosen as they both have been shown to carry Kac[4a,b,23]
and Kcr.[9] To date only two proteins have been shown to carry
the Kmyr modification on e-amino groups of lysine residues—
namely tumor necrosis factor-a (TNF-a)[11a] and interleukin 1a
(IL-1a)[24]—and we decided to base the probe sequence
around TNF-a K20. Glutarylation of numerous lysine residues
has been identified on multiple proteins. Carbamoyl phosphate
synthetase-1 (CPS-1) is among the proteins that has been most
extensively investigated in this context[8a] and we therefore
chose to design our probe sequence around CPS-1 K1356.
Previous investigations by Sieber and co-workers showed
that the commonly used benzophenone photo cross-linker
gave rise to high levels of non-specific binding.[25] Furthermore,
Li and co-workers found that using the diazirine photo cross-
linker „photo-Leu“ in close proximity to their modified lysine
was preferred.[19d] In light of this insight regarding the choice
and position of photo cross-linker, as well as preliminary results
from our own laboratory (unpublished), we designed the col-
lection of probe sequences outlined in Scheme 1A. In addition
to the mentioned e-amide bond analogues, we also prepared
the native oxoamide versions of the probes for comparison
(motifs A–C in Scheme 1B). Finally, four well-described acyl-
based PTMs to lysine were chosen (Kac, Kcr, Kmyr, and Kglut)
(Scheme 1C) and a collection of 36 probes out of the full
matrix of 48 combinations was synthesized (Table S1, Support-
ing Information (SI)). For control experiments and validation of
specificity, we also synthesized a non-acylated probe based on
sequence 1 and a number of competitor probes that contain
PTMs but are devoid of photo cross-linker and click handle (se-
quences 1C, 3C, and 4C ; Scheme 1D and Table S2, SI).
Briefly, a versatile a-N-Fmoc-d-N-Boc-e-N-Teoc-(d-aza)lysine
building block was designed for introduction of hydrazide
lysine-mimicking side chains on solid support (Scheme S1, SI)
and thioamide-containing building blocks were prepared using
Lawesson’s reagent[26] (Scheme S2, SI). After several failed at-
tempts to prepare the thiocrotonylated building block, poten-
tially due to instability of the a,b-unsaturated thioamide func-
tionality,[27] it was discarded from our investigation. A small se-
lection of additional probe constructs were furthermore omit-
ted from the series based on the results of initial screens (see
explanations vide infra). Thus, 36 different probes, systematical-
ly covering peptide sequences, lysine mimics, and PTMs (see
Table S1), were synthesized by standard automated Fmoc
solid-phase peptide synthesis (SPPS). Though, coupling of the
photo-leucine building block and introduction of the acyl
modifications in the hydrazide-based probes were performed
manually (Schemes S3 and S4, SI). The competitor sequences
were similarly synthesized (Schemes S5 and S6) and all pep-
tides were purified to >95% homogeneity by preparative re-
verse-phase HPLC separation and lyophilization of the fractions
that contained pure product, according to MALDI-TOF MS.
Optimization of ABP methodology using in-gel fluorescence
With the collection of probes in hand, we first optimized the
conditions for cross-linked adduct formation and subsequent
click chemistry using the native amide-containing control
probes based on H4K12 (1A sequences). We optimized the
enzyme–probe conjugate formation by applying sodium dode-
cyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
in-gel fluorescence measurements (SI, Figures S1–S5). For the
Figure 1. Overview of the developed methodology. Upon recognition of the
modified lysine, UV irradiation activates the photo cross-linker forming a co-
valent bond between probe and protein. Conjugation through click chemis-
try then allows visualization by in-gel fluorescence or streptavidin enrich-
ment followed by western blotting.
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photo cross-linking we applied UV irradiation (365 nm) for
10 min at 0 8C.[19d] First, we assessed the choice of ligand for
the CuI-catalyzed azide-alkyne 3+2 cycloaddition (CuAAC). In
our hands, the more polar ligands exhibited superior per-
formance than TBTA. Although different ligand effects may be
observed depending on the used buffers and reducing agents
as well, this finding was in agreement with a recent study of
hydrophilic ligands,[28] and we therefore chose BTTAA for fur-
ther experiments (see SI, Figure S1 for western blot analysis,
IUPAC names, and chemical structures). We then investigated
the efficiency of different copper-ligand ratios on the CuAAC.
Based on labeling of sirtuins 2 and 3 (Figure S2), the optimal
ratio of CuSO4-BTTAA was selected to be 1:2. Next, we ad-
dressed the amount of probe and the probe-fluorophore ratio,
using recombinant enzymes (1 mm) in the presence of HeLa
whole cell lysate (2 mgmL@1) to better mimic a cellular environ-
ment for the labeling reaction. The experiments revealed dose-
dependent and selective labeling of SIRT1, SIRT2, and SIRT5
(Figure 2A and Figure S3). Based on those results, it was decid-
ed to continue with 25 mm of probe and 20 equivalents of fluo-
rophore relative to this concentration, except when using the
Kmyr probes where 12.5 mm of probe was considered suffi-
cient. As evident from Figure 2A, the labeling experiments
using the acetylated probe (1A-Kac) led to significant labeling
of multiple proteins in the lysate in addition to the recombi-
nant SIRT3.
After this optimization, we performed a series of control ex-
periments to confirm that the fluorescent labeling of the en-
zymes relied on addition of probe, UV irradiation, CuSO4, and
fluorophore (Figure 2B and Figures S4 and S5). Furthermore, it
was confirmed that the non-cross-linking peptides Ac-H48-
17K12(myr)-NH2 (1
CA-Kmyr) and Ac-H48-17K12(glut)-NH2 (1
CA-
Kglut) do not lead to labeling, which allows for the use of
these peptides as competitors. Finally, the importance of the
lysine modification was further confirmed by applying a probe
without a PTM but still containing the photo cross-linker and
alkyne moieties (1-free amine, Table S2), which did not lead to
fluorescent bands.
Addressing the importance of PTM and peptide sequence
for sirtuin labeling
Encouraged by the above control experiments, we then sys-
tematically screened for the effect of peptide sequence (1–4)
and modified lysine motif (A–C) on the ability of the probes to
interact with the different sirtuins. It was gratifying to observe
that thioamide (1–4B)- and hydrazide (1–3C)-containing
probes were generally as well recognized by the enzymes as
the native oxoamides (1–4A) (see Figures S6–S21, Table S3, and
Figure 3 for extracted examples using Kmyr). The screening of
probe sequence 1 against a mixture of SIRT1-3 (Figure S6) re-
vealed that the 1C-Kac hydrazide-based probe performed simi-
Scheme 1. Nomenclature for the series of probes and competitors prepared in this study: (A) Sequences of the photo cross-linkable and clickable decamer
peptide probes based on H4, H3, TNF-a, and CPS-1 sequences (1–4, respectively). (B) Structures of the posttranslationally modified lysine residues A–C.
(C) Structures and abbreviations for the investigated PTMs. (D) Competitor sequences, lacking photo cross-linker and click handle, are named similar to the
probes but marked with a “C” in superscript 1C, 3C, 4C.
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larly to the native 1A-Kac probe, while the 1B-Kac thioacetylat-
ed probe significantly enhanced the labeling efficiency. There-
fore, it was decided to focus on thioacetylated probes rather
than the hydrazide versions of the acetylated probes. Some-
what surprisingly in light of the recent work by Cen and co-
workers,[22] however, the thioacetylated probes appeared to
substantially label most sirtuins, including SIRT4 and SIRT5,
which are not believed to target Kac[6a,8a,12] (Figure S10–S17).
Although, the observed differences in selectivity between our
more elaborate screening of probes and the previous report
may be explained by differences in experimental conditions,
we conclude that probes containing this modification may be
of limited utility and speculate that perhaps the hydrazide ver-
sions could rather be revisited after all. Nevertheless, we decid-
ed to focus the present investigation on non-Kac modifica-
tions.
Interestingly, the e-N-glutaryl-(d-aza)lysine-containing probe
(1C-Kglut) exhibited decreased labeling efficiency of SIRT5
compared to 1A-Kglut (Figure S14). This observation was pre-
sumably due to zwitter ion formation or intramolecular hydro-
gen bonding between the basic NH group of the hydrazide
and the terminal carboxylate. Based on this finding, we decid-
ed not to pursue the remaining hydrazide versions of the glu-
tarylated probes. The thioglutarylated probes, on the other
hand, are highly promising for the study of SIRT5, showing in-
creased labeling compared to the glutarylated probes, and
therefore potentially also for other proteins that may recognize
Kglut (Figure S14–S17).
The crotonylated hydrazide-based probes (1–3C-Kcr) robust-
ly labeled SIRT4, which is an interesting observation because
SIRT4 has never been connected with this PTM before and
therefore requires further investigation. In addition, future
work employing these chemotypes will include investigation
of recognition domains such as YEATS[29] as well as class I zinc-
dependent HDACs, which are believed to be the main regula-
tors of Kcr.[16]
The e-N-myristoyllysine-containing probe series efficiently la-
beled SIRT1-3 as expected[30] and also gave rise to substantial
fluorescent bands for SIRT7 (Figures S20 and S21), which is in
agreement with a recent study.[31] In general, we found that
Figure 2. Optimization of covalent adduct formation and control experiments applying in-gel fluorescence: (A) Optimization of probe concentration and
probe-fluorophore ratio required for labeling of SIRT1-3 and SIRT5 (1 mM enzyme concentrations). (B) Control experiments shown for 1A-Kmyr (12.5 mM)
showing that labeling is indeed dependent on all components added. See the Supporting Information for full gel images (Figures S3–S5).
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the PTMs more significantly affect probe efficacy
than the peptide sequence; albeit, with some excep-
tions. Therefore, we speculated that adding the hy-
drazide-based series of probes with sequence 4
would provide limited information and decided not
to include 4C probes in the collection. Interestingly,
the Kmyr-containing peptide sequences based on
TNF-a, which has been shown to be targeted by sir-
tuins,[11b] appeared to label SIRT2 with some degree
of selectivity over other sequences. This was particu-
larly pronounced when using the probes containing
the thioamide or hydrazide Kmyr mimics (Figure 3).
Stability of probes containing amide bond ana-
logues and competition experiments
Based on the above screening results, and because
the PTMs in question have been shown to regulate
the respective enzymes,[8a,11b] we selected the TNF-a
sequence (3) for probes containing Kmyr residues
and the CPS1 sequence (4) for glutarylated probes
for further experiments. First, we challenged the per-
formance of probes containing different lysine resi-
dues (A–C) by addition of NAD+ , the co-substrate of
sirtuins. This clearly resulted in a significant decrease
in fluorescence intensity for the oxoamide-containing
probes and in the case of Kmyr, a complete abolish-
ment of sirtuin labeling (Figure 4). However, the experiment
gratifyingly showed retention of fluorescent bands for the thio-
amide bond-containing probes 3B-Kmyr and 4B-Kglut as well
as the d-azalysine mimic 3C-Kmyr (Figure 4A, B and Fig-
ure S22).
Interestingly, the glutarylated probe 4B-Kglut even exhibited
more intense labeling of SIRT5 in the presence of NAD+ , which
could be explained by extended residence time in the enzyme
active site due to formation of a stalled intermediate between
probe and co-substrate. Taken together, this strongly indicates
that compromised structural integrity of probes that are based
on native PTMs (type A) could give rise to ambiguous results if
applied in a biological environment and shows that this chal-
lenge can be solved by applying non-cleavable amide bond
analogues (i.e. , thioamides or hydrazides). Importantly, we fur-
ther showed by competition experiments, that the novel PTM
mimics indeed bind to the sirtuin enzymes through specific
recognition that can be outcompeted by non-cross-linking,
PTM-modified peptides (Figure 4C, Figure S23 and supporting
discussion). The thioamide probe (3B-Kmyr) was more effi-
ciently outcompeted than the hydrazide probe (3C-Kmyr) and
was therefore selected for the further experiments.
Employing photo cross-linking probes for the enrichment of
native enzymes from cell lysates
With these encouraging proof-of-concept results from in-gel
fluorescence experiments, we next ventured into trapping of
native enzymes from whole cell lysates. Here, we employed
coupling of biotin to the protein-ABP conjugate instead of the
Figure 3. In-gel fluorescence showing efficiency of SIRT1–3 labeling using
myristoylated probes. Coomassie-stained gel is shown in blue-scale and in-
gel fluorescence is shown in gray-scale. Screening of the labeling efficiency
of different myristoylated probes (12.5 mM) against recombinant SIRT1-3
(1 mM) in pure buffer or buffer containing HeLa cell lysate (2 mgmL@1). The
concentration of SIRT2 was slightly lower than expected based on the pro-
tein concentration provided by the vendor, which we corrected for in later
experiments. See the Supporting Information (Figures S6–S21) for full gel
images and further discussion.
Figure 4. (A) Testing the performance of the myristoyl probes without or with NAD+
(500 mM) in the presence of recombinant SIRT1-3 (1 mM of each). (B) Testing the per-
formance of the glutaryl probes without or with NAD+ (500 mM) in the presence of re-
combinant SIRT5 (1 mM). (C) Competition of 3B-Kmyr (12.5 mM), 3C-Kmyr (12.5 mM) and
4B-Kglut (25 mM) against recombinant enzymes (1 mM) with 3CB-Kmyr, 3C-Kmyr, and
4CB-Kglut, respectively. See the Supporting Information for full gel images (Figures S22
and S23) and further discussion.
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fluorophore, followed by enrichment on streptavidin-coated
beads, and protein identification using western blot analysis.
Most ABPs developed for investigation of sirtuins have only
been evaluated using recombinant enzymes or with overex-
pressing cell lines thus far.[19b,22] A notable exception to this is
work from Li and co-workers, who have demonstrated enrich-
ment of endogenous SIRT3 and SIRT5 from HeLa whole cell
lysate using probes based on Kac and Kmal, respectively.[19d]
We show here the first examples of successful pull-down of en-
dogenous interaction partners for the Kmyr and Kglut post-
translational modifications. Thus, probes 3B-Kmyr and 4B-
Kglut were incubated with native HEK293 whole cell lysate
and different amounts of the corresponding competitor
probes. After elution from the streptavidin-coated beads the
samples were analyzed by western blotting (Figure 5).
Importantly, an extensive amount of experiments proved
necessary to optimize this protocol, which eventually showed
that the choice of beads was of tremendous importance. Thus,
at first sight, we achieved robust enrichment of several en-
zymes using both agarose beads and Dynabeads. However,
the control experiments revealed this to be accompanied by
substantial non-specific binding to the beads, which we un-
fortunately failed to eliminate, even after extensive washing
steps (see Figure S24 for details). Finally, a type of streptavidin
magnetic beads that could be washed properly was identified
and successfully employed for enrichment (Figure S24C).
Satisfyingly, both probes efficiently trapped and pulled
down the reported interaction partners SIRT2 and SIRT5, re-
spectively, when employing the optimized conditions
(Figure 5). With the myristoylated probe (3B-Kmyr) we en-
riched two isoforms of SIRT2 and the labeling was successfully
abolished by competition using 3CB-Kmyr for both bands. This
constitutes the first demonstration of a versatile photo cross-
linking probe that is able to enrich two different endogenous
and physiologically relevant splice variants of SIRT2 [i.e. , iso-
form 1 (43 kDa) and isoform 2 (39 kDa],[32] which underscores
the utility of our new probe design (Figure 5A). Affinity purifi-
cation of both splice variants of SIRT2 from HL60 cell lysate
has previously been demonstrated. However, this was achieved
by using beads coated with immobilized SirReal2, which is a
selective inhibitor of SIRT2 with long residence time in the
active site.[33]
We also attempted to enrich HDAC11 from MCF-7 cell
lysate, where this enzyme is abundantly expressed. Unfortu-
nately, these efforts failed, which we suspect may be due to
the low binding affinities (high KM values) recorded for Kmyr
substrates with HDAC11.[17]
Finally, the glutarylated probe (4B-Kglut) was able to form a
cross-linked adduct with and enrich endogenous SIRT5 and
this adduct formation was also outcompeted by the corre-
sponding 4CB-Kglut (Figure 5B).
Conclusions
In summary, we have developed a new strategy for photo
cross-linking probes to address the members of the proteome
that target e-N-acyllysine posttranslational modifications, which
are highly prevalent and constitute a continuously expanding
collection of chemical groups. We have harnessed design prin-
ciples from mechanism-based inhibitors of the sirtuin enzymes,
because this may allow for extended residence time in the tar-
geting enzyme’s pocket and, importantly, will preserve the in-
tegrity of the probe during the course of the experiment. Our
results are highly encouraging, as they corroborate the hy-
pothesis that we can install enzymatically stable amide bond
analogues, while retaining the ability of native interaction part-
ners in cell lysates to recognize the modification with high se-
lectivity and specificity. In addition, we provide the first investi-
gation of the importance of peptide sequence on performance
of e-N-acyllysine-containing photo cross-linking probes, screen-
ing the efficiency of a combined series of 36 probe constructs
against all 7 human sirtuins.
The developed methodology provides basis for detailed che-
moproteomics studies by combining our protocol with stable
isotope labeling with amino acids in cell culture (SILAC) tandem
mass spectrometry-based methods.[34] This will broaden the
potential of the technology beyond identification of the en-
dogenous “eraser” enzymes (i.e. , HDACs or sirtuins) as demon-
strated in this proof-of-concept study. With the enhanced
structural integrity of the probes, we expect that potential
reader domains can be identified as well.
Figure 5. Pull-down of endogenous proteins from HEK293 whole cell lysate:
(A) Pull-down of endogenous SIRT2 using 3B-Kmyr. Top membrane shows
samples before pull-down. Bottom membrane shows samples after pull-
down, including dose-dependent competition of the adduct formation.
(B) Pull-down of endogenous SIRT5 using 4B-Kglut. Top membrane shows
samples before pull-down. Bottom membrane shows samples after pull-
down, including dose-dependent competition of the adduct formation. *All
blots are performed in duplicates and can be seen in full in Figures S25 and
S26.
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Finally, the relatively simple design allows for easy prepara-
tion of novel probes containing different PTMs. Thus, with the
continuously expanding landscape of acyl modifications to
lysine residues in the human proteome,[35] discovered by
tandem mass spectrometry proteomics methods, we expect
this technology to find broad applications in the future.
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